<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02425696</url>
  </required_header>
  <id_info>
    <org_study_id>RLS-1dzx</org_study_id>
    <nct_id>NCT02425696</nct_id>
  </id_info>
  <brief_title>Registry of Right-to-left Shunt Detection by Contrast-enhanced Transcranial Doppler in Chinese Population</brief_title>
  <official_title>Registry of Right-to-left Shunt Detection by Contrast-enhanced Transcranial Doppler in Chinese Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yingqi Xing</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Hospital of Jilin University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate the prevalence and extent of right-to-left shunt
      (RLS) in Chinese migraineurs, and the morbidity of silent cerebral infarction in migraineurs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective multicenter study of Chinese population. Participants (normal
      individuals without migraine and migraineurs) are included after standardized diagnostic
      procedures (TCD and c-TCD). For migraineurs with large RLS further examinations (c-TTE and
      brain MRI) are required. Up to 10 study sites nationwide will be needed to recruit the
      planned participant population during a 1-year period.

      The information of each participants will be registered, including basic facts, the
      longitudinal headache history, frequency, location, quality, intensity, duration, accompanied
      symptoms, precipitating and exacerbating factors, with or without aura, MIDAS and HIT-6
      questionnaire.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2015</start_date>
  <completion_date type="Actual">August 2017</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>contrast-enhanced transcranial Doppler</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>brain MRI</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1100</enrollment>
  <condition>Right-to-left Shunt</condition>
  <condition>Migraine</condition>
  <condition>Cerebral Infarction</condition>
  <arm_group>
    <arm_group_label>group 1</arm_group_label>
    <description>Normal individuals without migraine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 2</arm_group_label>
    <description>Migraineurs</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        We detect RLS through contrast-enhanced transcranial Doppler (c-TCD). The normal
        individuals will be selected to group 1, while those who suffer from migraine will be
        selected to group 2. Patients of group 2 with large RLS are required to take TTE and brain
        MRI.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  For group 1: Normal healthy individual without migraine.

          -  For group 2: Clinical history of migraine diagnosed by a neurologist according to the
             International Classification of Headache Disorders.

        Exclusion Criteria:

          -  Subjects with stenotic intracranial or extracranial arteries or intracranial
             abnormalities diagnosed with TCD.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yingqi Xing, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>First Hospital of Jilin University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yi Yang, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>First Hospital of Jilin University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yuzhu Guo</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Hospital of Jilin University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jie Zhang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Hospital of Jilin University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sibo Wang</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Hospital of Jilin University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>First Hospital of Jilin University</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <zip>130000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 21, 2015</study_first_submitted>
  <study_first_submitted_qc>April 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 24, 2015</study_first_posted>
  <last_update_submitted>January 17, 2018</last_update_submitted>
  <last_update_submitted_qc>January 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>First Hospital of Jilin University</investigator_affiliation>
    <investigator_full_name>Yingqi Xing</investigator_full_name>
    <investigator_title>Director of Head and Neck Vascular Ultrasound Center</investigator_title>
  </responsible_party>
  <keyword>right-to-left shunt</keyword>
  <keyword>contrast-enhanced transcranial Doppler</keyword>
  <keyword>migraine</keyword>
  <keyword>silent cerebral infarction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Migraine Disorders</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

